FDA launches new priority review program for drugs

Congratulations to the new leadership at FDA on behalf of the American people and all our patients. A major step forward maintaining innovation and competitiveness with the rest of the world. @DrMakaryFDA @SecKennedy www.fda.gov/news-events/press-announcements/fda-issue-new-commissioners-national-priority-vouchers-companies-supporting-us-national-interests

NEW: FDA will give special drug-review vouchers to "companies aligned with U.S. national priorities" that shortens the 10-month drug review process to 1-2 months with a 1 day review board meeting. More from @LizzyLaw_ @statnews: www.statnews.com/2025/06/17/fda-new-priority-reviews-will-cut-months-off-drug-approvals/

This is not a common sense approach from @US_FDA but a dangerous one in shortening review times from 10-12 mos to 1-2 mos, putting even more uncertainty around efficacy & safety of new treatments onto patients and doctors. Other PRVs grant 6 mos review! www.fda.gov/news-events/press-announcements/fda-issue-new-commissioners-national-priority-vouchers-companies-supporting-us-national-interests

CNPV (Commissioner’s National Priority Voucher) program looks pretty cool 🧐 Imagine drug companies being able to shorten FDA review timeline from 10-12 months to just 1-2 months tinyurl.com/5hdhhu3y Small steps in the right direction to support the biotech sector $XBI $IBB